Anemia is a common health issue that can arise from various deficiencies, particularly in folate, vitamin B12, and serum ferritin. Poclight's anemia testing kits (CLIA) utilizes homogeneous chemiluminescent immunoassay to provide a thorough assessment of these key serum markers. This holistic approach aids clinicians in accurately diagnosing the underlying causes and types of anemia, facilitating early intervention and effective treatment for patients.

Traditional methods for anemia testing often have significant drawbacks. Many conventional techniques rely on complex procedures that can introduce variability and require extensive sample handling. These methods may also lack the sensitivity needed to detect subtle deficiencies, leading to potential misdiagnoses and delayed treatment. As a result, there's a pressing need for more reliable and streamlined testing solutions.

Poclight‘s anemia testing kits addresses these challenges with several distinct advantages. The innovative use of graphene oxide eliminates the need for magnetic beads, simplifying the process by removing separation and washing steps. This not only streamlines the workflow but also enhances the overall performance of the assay, increasing sensitivity by one to two orders of magnitude.

Moreover, Poclight's kits offers exceptional cost-effectiveness. The Lyophilized Beads reagent is designed for individual packaging, eliminating the need for refrigeration and significantly reducing the risks associated with transportation and storage. The compact design of our analyzer can be widely used in multiple scenarios, making them ideal for hospitals, clinics, and laboratories.

Poclight's anemia testing kits (CLIA), including Active-B12 (AB12) test kits (Homogeneous Chemiluminescence Immunoassay), Folate test kits (Homogeneous Chemiluminescence Immunoassay), stands out as a groundbreaking solution in the field of diagnostic testing. By combining advanced technology with practical design, we empower healthcare providers to deliver timely and accurate anemia diagnoses, ultimately improving patient outcomes.